Home›Companies›Artificial Intelligence›BranchLab

Branchlab Inc.

AI software helps pharmaceutical companies and their agencies find and reach healthcare audiences.

Updated Nov 10, 2026·Latest SEC filing May 20, 2026·Suggest an edit

About BranchLab

BranchLab is a private company based in New York, New York. It has reported $28,784,986 raised in two offerings on Form D since April 2024. Its chief executive is Joshua Walsh.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 4, 2026May 20, 2026$28,784,986fully sold27$1.0MEquityRule 506(b)Form D ↗
Not yetApr 2, 2024$0target not set0—Options, Securities on exerciseRule 506(b)Form D ↗
Total, two offerings$28,784,986

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on BranchLab's Form D filed May 20, 2026.

Michael Parkes
Michael Parkes
President & CRO, director
Joshua Walsh
Joshua Walsh
CEO and director
CW
AB

Earlier filings also listed Christopher Cagle (executive officer and director, last listed Apr 2024).

Sources

  1. SECBRANCHLAB INC. filing history
  2. CompanyBranchLab leadership
  3. PressBranchLab Series A announcement